12 Health Care Stocks Moving In Thursday's Pre-Market Session

Loading...
Loading...

 

Gainers

  • Kiromic BioPharma KRBP shares rose 32.5% to $1.04 during Thursday's pre-market session. The company's market cap stands at $16.0 million.
  • DBV Technologies DBVT stock moved upwards by 23.07% to $1.6. The company's market cap stands at $175.7 million. The company's, Q4 earnings came out today.
  • Tonix Pharmaceuticals TNXP shares increased by 20.3% to $0.23. The company's market cap stands at $114.0 million.
  • X4 Pharmaceuticals XFOR stock rose 11.16% to $2.19. The company's market cap stands at $65.1 million.
  • Roivant Sciences ROIV stock rose 8.45% to $6.8. The market value of their outstanding shares is at $4.7 billion.
  • Organovo Holdings ONVO stock rose 8.01% to $4.58. The market value of their outstanding shares is at $39.8 million.

 

Losers

  • NuCana NCNA stock decreased by 55.5% to $1.31 during Thursday's pre-market session. The market value of their outstanding shares is at $68.3 million.
  • Veeva Systems VEEV shares fell 9.6% to $208.49. The market value of their outstanding shares is at $32.0 billion. The company's, Q4 earnings came out yesterday.
  • Exicure XCUR shares declined by 9.44% to $0.24. The company's market cap stands at $25.9 million.
  • Trevi Therapeutics TRVI stock declined by 7.83% to $1.06. The market value of their outstanding shares is at $27.3 million.
  • Quoin Pharmaceuticals QNRX stock declined by 7.76% to $1.07. The market value of their outstanding shares is at $8.9 million.
  • Recursion Pharmaceuticals RXRX stock declined by 7.36% to $9.95. The company's market cap stands at $1.6 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...